Mycenax Biotech Inc.

Mycenax Biotech Inc.verified

4726.TWO

Price:

$32.4

Market Cap:

$6.72B

Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian and microbial cell lines in Taiwan, Europe, Asia, and the United States. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), as well as plasmids and DNA vaccines. It also provides process development solutions, including development of production cell lines, upstream and downstream process development, process scale-up, formulation development, and analytical methods; in-house analytical services...[Read more]

Industry

Biotechnology

IPO Date

2012-06-20

Stock Exchange

TWO

Ticker

4726.TWO

The Enterprise Value as of December 2025 (TTM) for Mycenax Biotech Inc. (4726.TWO) is 7.49B

According to Mycenax Biotech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.49B. This represents a change of -20.63% compared to the average of 9.43B of the last 4 quarters.

Mycenax Biotech Inc. (4726.TWO) Historical Enterprise Value (quarterly & annually)

How has 4726.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Mycenax Biotech Inc. over the last ten years is 5.98B. The current 7.49B Enterprise Value has changed 12.43% with respect to the historical average. Over the past ten years (40 quarters), 4726.TWO's Enterprise Value was at its highest in in the June 2024 quarter at 13.11B. The Enterprise Value was at its lowest in in the December 2023 quarter at 7.45B.

Quarterly (TTM)
Annual

Average

5.98B

Median

5.96B

Minimum

2.92B

Maximum

9.55B

Mycenax Biotech Inc. (4726.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mycenax Biotech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 51.12%

Maximum Annual Enterprise Value = 9.55B

Minimum Annual Increase = -4.15%

Minimum Annual Enterprise Value = 2.92B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20249.55B28.48%
20237.44B27.50%
20225.83B-4.15%
20216.09B51.12%
20204.03B37.83%

Mycenax Biotech Inc. (4726.TWO) Average Enterprise Value

How has 4726.TWO Enterprise Value performed in the past?

The current Enterprise Value of Mycenax Biotech Inc. (4726.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

7.61B

5-year avg

6.59B

10-year avg

5.98B

Mycenax Biotech Inc. (4726.TWO) Enterprise Value vs. Peers

How is 4726.TWO’s Enterprise Value compared to its peers?

Mycenax Biotech Inc.’s Enterprise Value is greater than CHO Pharma, Inc. (6.50B), greater than Pharmosa Biopharm Inc. (6.25B), less than TaiGen Biopharmaceuticals Holdings Limited (8.09B), greater than OBI Pharma, Inc. (6.31B), greater than Sinphar Pharmaceutical Co.,Ltd. (6.62B), less than Adimmune Corporation (9.19B), greater than Acepodia, Inc. (3.82B), greater than AnnJi (3.93B), greater than Formosa Pharmaceuticals, Inc. (4.02B), greater than Panion & Bf Biotech Inc. (5.87B),

Build a custom stock screener for Mycenax Biotech Inc. (4726.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mycenax Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mycenax Biotech Inc. (4726.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mycenax Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Mycenax Biotech Inc.'s Enterprise Value?

What is the highest Enterprise Value for Mycenax Biotech Inc. (4726.TWO)?

What is the 3-year average Enterprise Value for Mycenax Biotech Inc. (4726.TWO)?

What is the 5-year average Enterprise Value for Mycenax Biotech Inc. (4726.TWO)?

How does the current Enterprise Value for Mycenax Biotech Inc. (4726.TWO) compare to its historical average?